Erik Buntinx

552 total citations
10 papers, 44 citations indexed

About

Erik Buntinx is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Erik Buntinx has authored 10 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Erik Buntinx's work include Treatment of Major Depression (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Receptor Mechanisms and Signaling (3 papers). Erik Buntinx is often cited by papers focused on Treatment of Major Depression (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Receptor Mechanisms and Signaling (3 papers). Erik Buntinx collaborates with scholars based in Belgium, United States and Netherlands. Erik Buntinx's co-authors include Thomas E. Schläepfer, Filip De Vos, Charles Yu, Maya Hites, Huiling Chen, Edison Alberto, G. Crawford, Kurt Audenaert, Eva Vandermeulen and Ping Li and has published in prestigious journals such as Psychological Medicine, Vaccine and The International Journal of Neuropsychopharmacology.

In The Last Decade

Erik Buntinx

10 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Buntinx Belgium	5	15	11	8	7	5	10	44
Prabhakar Reddy India	3	22 1.5×	6 0.5×	16 2.0×	5 0.7×	4 0.8×	3	60
Thorsten Brodersen Denmark	5	15 1.0×	2 0.2×	6 0.8×	7 1.0×	1 0.2×	13	72
Nick Power Australia	2	16 1.1×	8 0.7×	2 0.3×	2 0.3×	4 0.8×	3	43
Neeraj Manikath India	4	7 0.5×	5 0.5×	9 1.1×	3 0.4×		6	69
José Carlos González Spain	5	9 0.6×	4 0.4×	2 0.3×	9 1.3×	2 0.4×	9	62
Margit Anita Hørup Larsen Denmark	4	33 2.2×	2 0.2×	18 2.3×	4 0.6×		6	53
J. P. Aquino France	3	5 0.3×	5 0.5×	12 1.5×	30 4.3×	10 2.0×	6	69
Álex Handy United Kingdom	4	11 0.7×		6 0.8×	6 0.9×	3 0.6×	5	42
Karl Erik Müller Norway	2	12 0.8×	2 0.2×	17 2.1×	4 0.6×		2	31
Nadège Néant France	3	37 2.5×	4 0.4×	4 0.5×	7 1.0×		3	43

Countries citing papers authored by Erik Buntinx

Since Specialization

Citations

This map shows the geographic impact of Erik Buntinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Buntinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Buntinx more than expected).

Fields of papers citing papers by Erik Buntinx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Buntinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Buntinx. The network helps show where Erik Buntinx may publish in the future.

Co-authorship network of co-authors of Erik Buntinx

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Buntinx. A scholar is included among the top collaborators of Erik Buntinx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Buntinx. Erik Buntinx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Vaissière, Nathalie, Carla Truyers, Erik Buntinx, et al.. (2025). Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial. EClinicalMedicine. 79. 103016–103016. 1 indexed citations

Salas, José A., Elizabeth Merrall, Erik Buntinx, et al.. (2024). Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial. Vaccine. 43(Pt 1). 126514–126514. 4 indexed citations

Buntinx, Erik, Charissa Borja-Tabora, Charles Yu, et al.. (2023). Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study. Vaccine. 41(11). 1875–1884. 10 indexed citations

López, Pío, Lulu Bravo, Erik Buntinx, et al.. (2023). Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents. Human Vaccines & Immunotherapeutics. 19(1). 2206359–2206359. 4 indexed citations

Wade, Alan, G. Crawford, Charles B. Nemeroff, et al.. (2011). Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Psychological Medicine. 41(10). 2089–2097. 10 indexed citations

Schatzberg, Alan F., et al.. (2011). P.2.a.018 Interaction of pimpamperone, citalopram and genetic variables in the prediction of antidepressant response. European Neuropsychopharmacology. 21. S364–S364. 1 indexed citations

Buntinx, Erik, et al.. (2010). P.2.d.011 Low dose pipamperone, enhancing antidepressant effect of citalopram, occupies 5HT2A 50–60% leaving D2 nearly drug free. European Neuropsychopharmacology. 20. S396–S397. 2 indexed citations

Buntinx, Erik, Kathelijne Peremans, Thomas E. Schläepfer, et al.. (2008). Preclinical and clinical evidence for the efficacy of pipamperone in augmenting the antidepressant effects of the SSRI citalopram. The International Journal of Neuropsychopharmacology. 11. 190–190. 1 indexed citations

Peremans, Kathelijne, Bart De Spiegeleer, Erik Buntinx, et al.. (2008). Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain. Nuclear Medicine Communications. 29(8). 724–729. 10 indexed citations

10.

Audenaert, Kurt, Bart De Spiegeleer, Erik Buntinx, et al.. (2008). Imaging of the serotin-2A receptor in the canine brain: Before a d after pipamperone administration. European Psychiatry. 23. S187–S187. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact